Focal Therapeutics
RELATED CONTENT
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the second leading cause of death in women, according to the American Cancer Society. Advances in technology continue to become available to aid in the fight against breast cancer which can improve the chances of beating the disease. David Weintritt, M.D., founder of the National Breast Center and National Breast Center Foundation, recently identified the top three technologies impacting the future of breast cancer treatment to improve outcomes for women diagnosed with the disease.
October 11, 2017 
Patients who were implanted with the BioZorb 3-D bioabsorbable marker during their lumpectomy could be treated with smaller radiation volumes than patients who did not receive the marker, according to new research. The findings were presented at the recent American Society of Breast Surgeons (ASBrS) annual meeting, April 26-30 in Las Vegas. The difference in volumes was statistically significant.
May 30, 2017 
A new research study concluded that use of the BioZorb surgical marker appears to provide better cosmetic outcomes and may be associated with an increased use of breast-conserving surgery. The study was conducted by Arkansas surgical oncologist Michael Cross, M.D., F.A.C.S.
May 12, 2017 
November 1, 2016 — Two new studies have documented the value of the BioZorb marker in improving the treatment of women ...
November 01, 2016 
Focal Therapeutics, makers of the three-dimensional BioZorb implant used in breast conservation therapy, announced it has launched BioZorb LP.
April 13, 2016 
Breast cancer research conducted by two Fayetteville, Arkansas, medical groups highlights their success in pioneering use of an absorbable, three-dimensional marker used during treatment for breast cancer. Their cost analysis, to be presented at an international breast cancer conference this week, showed that by helping to shorten the course of radiation treatments, the surgical marker contributed to a 25 percent cost savings per patient.
September 22, 2015 
A Coral Springs, Florida, surgeon is among the first in the state to adopt an innovative new device that improves the treatment of breast cancer.
August 05, 2015 
A Noble Hospital breast surgeon's work with a new device that improves treatment of breast cancers will be featured later this month at a prestigious international medical conference.
February 26, 2015 
A new surgical device enables breast cancer patients to be treated with dramatically improved targeting of radiation. Findings were presented at the 18th SIS World Congress on Breast Healthcare. The congress was co-hosted by the Senologic International Society (SIS) and the American Society of Breast Disease (ASBD).
January 08, 2015 
The trend in breast cancer treatment these days is all about precision, with the twin goals of controlling the cancer better and reducing side effects. Great advances have been made in radiation delivery methods that make it possible to more precisely target the tumor bed, plus a small margin around it where the cancer would be most likely to recur. By tightly focusing on these areas alone, radiation oncologists can minimize exposure to critical healthy tissue and structures such as the heart and lungs. Less damage to healthy tissue also means better cosmetic outcomes.
October 03, 2014